Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results

Clinics and Research in Hepatology and Gastroenterology

Volumn 37, Issue 2, 2013, Pages 152-158

  Başar, Ömer ^a   Yimaz, Bariş ^a   Ekiz, Fuat ^a   Giniş, Zeynep ^a   Altinbaş, Akif ^a   Aktaş, Bora ^a   Tuna, Yaşar ^b   Çoban, Şahin ^a   Delibaş, Namik ^a   Yüksel, Osman ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; ENTECAVIR; LAMIVUDINE; TENOFOVIR;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; BLOOD SAMPLING; CROSS-SECTIONAL STUDY; FEMALE; FORN INDEX; HEPATITIS B; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREDICTION; S INDEX; SHANGHAI LIVER FIBROSIS GROUP INDEX;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BIOPSY, FINE-NEEDLE; CROSS-SECTIONAL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEMATOLOGIC TESTS; HEMOGLOBINS; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84876744072     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2012.07.003     Document Type: Article

References (24)

1. Zeng M.D., Lu L.G., Mao Y.M., et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology 2005, 42:1437-1445.
2. Lee W.M. Hepatitis B virus infection. N Engl J Med 1997, 337:1733-1745.
3. Afdhal N.H., Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004, 99:1160-1174.
4. Little A.F., Ferris J.V., Dodd G.D., et al. Image guided percutaneous hepatic biopsy: effect of ascites on the complication rate. Radiology 1996, 199:79-83.
5. Lindor K.D., Bru C., Jorgensen R.A., et al. The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology 1996, 23:1079-1083.
6. Cadranel J.F., Rufat P., Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000, 32:477-481.
7. Imbert-Bismut F., Ratziu V., Pieroni L., et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001, 357:1069-1075.
8. Wai C.T., Greenson J.K., Fontana R.J., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003, 38:518-526.
9. Forns X., Ampurdanès S., Llovet J.M., et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002, 36:986-992.
10. Sterling R.K., Lissen E., Clumeck N., et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006, 43:1317-1325.
11. Gressner O.A., Weiskirchen R., Gressner A.M. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta 2007, 381:107-113.
12. Adams L.A., Bulsara M., Rossi E., et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005, 51:1867-1873.
13. Calès P., Oberti F., Michalak S., et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005, 42:1373-1381.
14. Zhou K., Gao C.F., Zhao Y.P., et al. Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. J Gastroenterol Hepatol 2010, 25:1569-1577.
15. The French METAVIR Cooperative Study Group Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994, 20:15-20.
16. Wai C.T., Cheng C.L., Wee A., et al. Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver Int 2006, 26:666-672.
17. Sebastiani G., Vario A., Guido M., et al. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2007, 13:525-531.
18. Wu S.D., Wang J.Y., Li L. Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: a comparative study. World J Gastroenterol 2010, 16:501-507.
19. Vallet-Pichard A., Mallet V., Nalpas B., et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 2007, 46:32-36.
20. Adler M., Gulbis B., Moreno C., et al. The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases. Hepatology 2008, 47:762-763.
21. Raftopoulos S.C., George J., Bourliere M., et al. Comparison of noninvasive models of fibrosis in chronic hepatitis B. Hepatol Int 2011, 10.1007/s12072-011-9296-5.
22. Naveau S., Gaudé G., Asnacios A., et al. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology 2009, 49:97-105.
23. Adams L.A., George J., Bugianesi E., et al. Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2011, 26:1536-1543.
24. Zarski J.P., Sturm N., Guechot J., et al. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. J Hepatol 2012, 56:55-62.